Submitted by Anonymous (not verified) on 25 July 2025 - 9:37
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 16, Status: Authorised
Source: